{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:20:17Z","timestamp":1790698817141,"version":"4.1.0"},"reference-count":25,"publisher":"BMJ","license":[{"start":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T00:00:00Z","timestamp":1548115200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.bmj.com\/company\/legal-information\/terms-conditions\/legal-information\/tdm-licencepolicy"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ"],"DOI":"10.1136\/bmj.k5198","type":"journal-article","created":{"date-parts":[[2019,1,22]],"date-time":"2019-01-22T14:56:33Z","timestamp":1548168993000},"page":"k5198","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":26,"title":["Elimination of lymphatic filariasis in South East Asia"],"prefix":"10.1136","author":[{"given":"Sabine","family":"Specht","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T K","family":"Suma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Belen","family":"Pedrique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Achim","family":"Hoerauf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2019,1,22]]},"reference":[{"key":"key20190314145725_ref1","first-page":"589","article-title":"Summary of global update on preventive chemotherapy implementation in 2016: crossing the billion","volume":"92","author":"World Health Organization","year":"2017","journal-title":"Wkly Epidemiol Rec"},{"key":"key20190314145725_ref2","unstructured":"WHO SEARO. Neglected tropical diseases: Lymphatic filariasis. http:\/\/www.searo.who.int\/entity\/vector_borne_tropical_diseases\/topics\/lymphatic_filariasis\/en\/"},{"key":"key20190314145725_ref3","unstructured":"World Health Organization. Lymphatic filariasis: progress report 2000-2009 and strategic plan 2010-2020. WHO\/HTM\/NTD\/PCT\/20106. 2010."},{"key":"key20190314145725_ref4","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003319"},{"key":"key20190314145725_ref5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000668"},{"key":"key20190314145725_ref6","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-3156.2005.01442.x"},{"key":"key20190314145725_ref7","first-page":"358","article-title":"Report on the mid-term assessment of microfilaraemia reduction in sentinel sites of 13 countries of the Global Programme to Eliminate Lymphatic Filariasis","volume":"79","author":"World Health Organization","year":"2004","journal-title":"Wkly Epidemiol Rec"},{"key":"key20190314145725_ref8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0005631"},{"key":"key20190314145725_ref9","doi-asserted-by":"publisher","DOI":"10.1093\/clinids\/23.5.1007"},{"key":"key20190314145725_ref10","doi-asserted-by":"publisher","DOI":"10.3347\/kjp.2008.46.3.119"},{"key":"key20190314145725_ref11","unstructured":"World Health Organization. Monitoring and epidemiological assessment of mass drug administration in the global programme to eliminate lymphatic filariasis: a manual for national elimination programmes. WHO, 2011. https:\/\/www.who.int\/iris\/handle\/10665\/44580."},{"key":"key20190314145725_ref12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0003281"},{"key":"key20190314145725_ref13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0006066"},{"key":"key20190314145725_ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002447"},{"key":"key20190314145725_ref15","doi-asserted-by":"publisher","DOI":"10.1186\/s13071-018-2616-z"},{"key":"key20190314145725_ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-015-0946-4"},{"key":"key20190314145725_ref17","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1207594"},{"key":"key20190314145725_ref18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0002508"},{"key":"key20190314145725_ref19","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/civ882"},{"key":"key20190314145725_ref20","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy003"},{"key":"key20190314145725_ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(16)30467-4"},{"key":"key20190314145725_ref22","unstructured":"World Health Organization. Guideline\u2014Alternative mass drug administration regimens to eliminate lymphatic filariasis. WHO\/HTM\/NTD\/PCT\/201707. 2017."},{"key":"key20190314145725_ref23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.0020092"},{"key":"key20190314145725_ref24","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cis486"},{"key":"key20190314145725_ref25","first-page":"149","volume-title":"Disease eradication in the 21st century: Implications for global health.","author":"Damian","year":"2011"}],"container-title":["BMJ"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/data.bmj.org\/tdm\/10.1136\/bmj.k5198","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmj.k5198","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,25]],"date-time":"2020-09-25T20:56:09Z","timestamp":1601067369000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.bmj.com\/lookup\/doi\/10.1136\/bmj.k5198"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,22]]},"references-count":25,"alternative-id":["10.1136\/bmj.k5198"],"URL":"https:\/\/doi.org\/10.1136\/bmj.k5198","relation":{},"ISSN":["0959-8138","1756-1833"],"issn-type":[{"value":"0959-8138","type":"print"},{"value":"1756-1833","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,22]]}}}